DaimlerChrysler has the third largest automotive
DaimlerChrysler is one of the world’s largest
automotive, transportation and services companies.
It has manufacturing operations in 37 countries and
distribution operations in more than 200 countries.
In 2001, it employed 372,000 people, its revenues
were US$ 136 billion and its net income was US$ 590
DaimlerChrysler South Africa (DCSA) has three main
plants that manufacture, market, import and export
motor vehicles and automotive parts. East London is
their largest facility with 79% of the workforce.
They also provide financial and fleet management
services. In 2001, DCSA had 4,500 employees and
3,000 suppliers and contractors working at these
three facilities. Although not part of the workplace
and community projects, DCSA indirectly impacts
2,900 other workers who are members of other
DaimlerChrysler affiliates or employed as part of
the dealer network. DCSA.s estimated 2001 revenues
were US$ 1.4 billion and its 2001 net income was US$
DCSA established its workplace and community HIV/AIDS
project in 2001 to address the increasing financial
burden associated with HIV/AIDS. DCSA also decided to
provide prevention, care, support and treatment services
to employees, their dependants and the community as part
of DCSA.s obligation to these stakeholders based on the
principles of corporate social responsibility (CSR).
This is also an extension of DaimlerChrysler's signing
of the UN Global Compact on CSR.
DCSA established a programme objective to reduce
further spread of HIV infections and Sexually
Transmitted Infections (STIs) and ensure access to
treatment, care and support for people living with
HIV/AIDS among the workforce of DCSA, their families
and their immediate communities and to effectively
manage the impact of HIV/AIDS on DCSA.
DCSA estimated a 2001 HIV prevalence of 9% in 2001.
Further, DCSA had observed an increase in the
proportion of employee deaths attributable to
HIV/AIDS since 1997; although no increase in the
death rate has been detected. In 2002, DCSA
estimated that the average present value cost per
HIV infection is US$ 31,000. In the forecasted peak
year for HIV/AIDS related expenditures, DCSA
forecasted expenses equivalent to 4% of DCSA.s
In order to determine whether or not the project was
effective, German Technical Cooperation (GTZ) and
DCSA established project process and outcome
indicators aligned with project objectives and
DCSA.s 2002 HIV/AIDS project budget is US$ 44 per
employee per year or 0.5% of payroll.
DCSA formed a partnership with labour, represented by
the National Union of Metalworkers of South Africa,
management and GTZ to prevent new infections, to provide
care, support and treatment for HIV+ employees and
dependants and to play an advocacy role regarding
HIV/AIDS interventions at the workplace, in the
community and at provincial and national levels.
DCSA first codified its HIV/AIDS workforce policies
in 1996. The policy is updated annually in the first
quarter of every year and the most recent version
was written in April 2002. Each version is signed
and approved by the union and management.
Workplace prevention programmes focus on behaviour
change through intensive employee and management
education, utilization of a peer educator approach,
services of nurse practitioner counsellors, condom
promotion and distribution, and Voluntary
Counselling and Testing (VCT).
Every employee is required to belong to the
Corporate Health Plan, which ensures funding for
HIV/AIDS treatment for employees and dependants (Aid
for AIDS (AFA) disease management programme)
including Highly Active Anti-Retroviral Treatment (HAART).
Each business unit also provides wellness programmes,
which can include general health promotion,
nutritional support and counselling, Syndromic STI
management, tuberculosis (TB) treatment through
Directly Observed Therapy Short course (DOTS) and
health status monitoring.
DCSA and GTZ regularly review project performance.
GTZ and DCSA are contractually obligated to submit
regularly scheduled activity and outcome reports.
The reports measure and analyse specific processes,
outcomes and interventions dictated by the
co-authored project strategy and operational plan
Upon completion of the project, DCSA will conduct an
HIV seroprevalence survey and a Knowledge, Attitude,
Perceptions and Behaviour (KAPB) profile assessment.
DCSA and GTZ will continue to focus on project
interventions dictated by the project operational plans
but will also focus on community interventions,
assessing the cost-benefit impact of prevention and
treatment, and institutionalization of the project.outh
Africa regularly reviews and adapts project performance.